Publications by authors named "A M Nomeir"

Aim Of The Study: This study aimed to evaluate the methylation status of two genes in the peripheral blood as possible non-invasive biomarkers for hepatocellular carcinoma (HCC) development in Egyptian patients with hepatitis C virus (HCV)-related liver cirrhosis, compare them with α-fetoprotein (AFP), and assess their relationship with the clinicopathological characteristics of the tumor.

Material And Methods: Thirty healthy volunteers, forty patients with HCC on top of HCV-associated liver cirrhosis, and forty patients with HCV-associated liver cirrhosis participated in this study. Using methylation-specific polymerase chain reaction (MSP), the methylation status of and was assessed.

View Article and Find Full Text PDF
Article Synopsis
  • HCV NS5A inhibitors, like MK-8325, have demonstrated strong effectiveness in lab tests for treating hepatitis C virus (HCV)
  • MK-8325 is a new drug that combines silyl proline and targets the NS5A protein, showing broad effectiveness across different HCV genotypes
  • The drug also has favorable absorption and distribution characteristics, making it a promising candidate for oral treatment combinations
View Article and Find Full Text PDF

In this paper we describe our strategy to improve the aqueous solubility of SCH 900229, a potent PS1-selective γ-secretase inhibitor for the treatment of Alzheimer's disease. Incorporation of ionizable amino groups into the side chain terminal generates water soluble β-aminosulfone analogues of SCH 900229 that maintain robust in vitro potency and in vivo efficacy.

View Article and Find Full Text PDF

Herein, we describe our research efforts to develop unique cores in molecules which function as HCV nonstructural protein 5A (NS5A) inhibitors. In particular, various fused tetracyclic cores were identified which showed genotype and mutant activities comparable to the indole-based tetracyclic core.

View Article and Find Full Text PDF
Article Synopsis
  • A matched and mixed capping SAR study was performed on tetracyclic indole compounds targeting HCV NS5A inhibitors.
  • The study aimed to explore how changes to this chemical structure affect their effectiveness against the hepatitis C virus.
  • Results from the study provide insights into how modifications can influence the virus's resistance to these inhibitors.
View Article and Find Full Text PDF